The Philippines FDA has issued Advisory No. 2023 – 1881 entitled “Pilot Implementation of the Food and Drug Administration Customer Relation Management Information System (CRMIS) which is an digital platform that will allow stakeholders and general public to submit inquiries, follow – ups, and other concerns via this link http://contact.fda.gov.ph/
Details of its implementation is tabulated below:
| Types of Transactions |
|
| Start Date | August 28, 2023 |
| End Date | November 30, 2023 |
In addition to this advisory, Annex A and Annex B are also attached to guide the stakeholders on the submission of requests through the CRMIS and to provide procedure on the use of the FDA CRMIS.
Read information about this advisory here.
Annexes for the advisory can be found below:
If you have any queries about this announcement, please contact us at sales@andamanmed.com or click the button below.
